Sarepta Therapeutics, Inc.·4

Mar 9, 8:02 PM ET

Mayo Stephen 4

4 · Sarepta Therapeutics, Inc. · Filed Mar 9, 2022

Insider Transaction Report

Form 4
Period: 2022-03-07
Mayo Stephen
Director
Transactions
  • Award

    Common Stock

    2022-03-07+2,9537,245 total
  • Award

    Stock Option (right to buy)

    2022-03-07+5,0775,077 total
    Exercise: $80.42From: 2023-03-07Exp: 2032-03-07Common Stock (5,077 underlying)
Footnotes (1)
  • [F1]The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 7, 2023.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION